Understanding crypticity is the key to revealing the pathogenesis of autoimmunity

Trends in Immunology

Volumn 26, Issue 7, 2005, Pages 355-359

  Moudgil, Kamal D ^a   Sercarz, Eli E ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITOPE; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYELIN BASIC PROTEIN; PEPTIDE DERIVATIVE; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANCER IMMUNIZATION; HASHIMOTO DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CLONING; NONHUMAN; PATHOGENESIS; PATHOGENICITY; RECEPTOR AFFINITY; REVIEW; T LYMPHOCYTE; THEORETICAL STUDY; THYMUS; TUMOR IMMUNITY;

EID: 20644444567     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2005.05.007     Document Type: Article

References (40)

1. N.R. Rose, and E. Witebsky Studies on organ specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts J. Immunol. 76 1956 417 427
2. E.E. Sercarz Dominance and crypticity of T cell antigenic determinants Annu. Rev. Immunol. 11 1993 729 766
3. E.E. Sercarz Driver clones and determinant spreading J. Autoimmun. 14 2000 275 277
4. R. Cibotti Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants Proc. Natl. Acad. Sci. U. S. A. 89 1992 416 420
5. K.D. Moudgil, and E.E. Sercarz Dominant determinants in hen eggwhite lysozyme correspond to the cryptic determinants within its self-homologue, mouse lysozyme: implications in shaping of the T cell repertoire and autoimmunity J. Exp. Med. 178 1993 2131 2138
6. K.D. Moudgil The self-directed T cell repertoire against mouse lysozyme reflects the influence of the hierarchy of its own determinants and can be engaged by a foreign lysozyme J. Immunol. 163 1999 4232 4237
7. +T cells during negative selection results in an altered antiviral T cell hierarchy J. Immunol. 170 2003 1231 1239
8. G. Benichou Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides J. Exp. Med. 172 1990 1341 1346
9. G. Gammon, and E. Sercarz How some T cells escape tolerance induction Nature 342 1989 183 185
10. P.V. Lehmann Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen Nature 358 1992 155 157
11. A. Rosen Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma Curr. Opin. Rheumatol. 9 1997 538 543
12. C.L. Vanderlugt, and S.D. Miller Epitope spreading in immune-mediated diseases: implications for immunotherapy Nat. Rev. Immunol. 2 2002 85 95
13. W.J. Lipham Recognition of peptides that are immunopathogenic but cryptic. Mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes J. Immunol. 146 1991 3757 3762
14. M.J. Mamula Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins J. Biol. Chem. 274 1999 22321 22327
15. P.J. Fairchild The nature of cryptic epitopes within the self-antigen myelin basic protein Int. Immunol. 8 1996 1035 1043
16. N.J. Viner Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing J. Immunol. 156 1996 2365 2368
17. K.D. Moudgil Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues J. Exp. Med. 183 1996 535 546
18. K.D. Moudgil Modulation of the immunogenicity of antigenic determinants by their flanking residues Immunol. Today 19 1998 217 220
19. B. Maecker Identification of a new HLA-A*0201-restricted cryptic epitope from CYP1B1 Int. J. Cancer 115 2005 333 336
20. P. Sinha Mouse lysozyme-M knockout mice reveal how the self-determinant hierarchy shapes the T cell repertoire against this circulating self antigen in wild-type mice J. Immunol. 173 2004 1763 1771
21. K.D. Moudgil, and E.E. Sercarz The self-directed T cell repertoire: its creation and activation Rev. Immunogenet. 2 2000 26 37
22. L. Klein CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium J. Exp. Med. 188 1998 5 16
23. O.S. Targoni, and P.V. Lehmann Endogenous myelin basic protein inactivates the high avidity T cell repertoire J. Exp. Med. 187 1998 2055 2063
24. C.J. Harrington Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein Immunity 8 1998 571 580
25. D. Avichezer An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms J. Exp. Med. 198 2003 1665 1676
26. F. Mor, and I.R. Cohen Pathogenicity of T cells responsive to diverse cryptic epitopes of myelin basic protein in the Lewis rat J. Immunol. 155 1995 3693 3699
27. R.R. Singh T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus J. Exp. Med. 181 1995 2017 2027
28. G. Carayanniotis The cryptic self in thyroid autoimmunity: the paradigm of thyroglobulin Autoimmunity 36 2003 423 428
29. Y. Dai Enhancing or suppressive effects of antibodies on processing of a pathogenic T cell epitope in thyroglobulin J. Immunol. 162 1999 6987 6992
30. Y. Li Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat J. Immunol. 172 2004 3225 3234
31. M. Durai The regulatory C-terminal determinants within mycobacterial heat shock protein 65 are cryptic and cross-reactive with the dominant self homologs: implications for the pathogenesis of autoimmune arthritis J. Immunol. 173 2004 181 188
32. M. Durai The T cells specific for the carboxyl-terminal determinants of self (rat) heat-shock protein 65 escape tolerance induction and are involved in regulation of autoimmune arthritis J. Immunol. 172 2004 2795 2802
33. K.D. Moudgil, and E.E. Sercarz Can antitumor immune responses discriminate between self and nonself? Immunol. Today 15 1994 353 355
34. A. Scardino HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy J. Immunol. 168 2002 5900 5906
35. +T cell responses to self- and mutated p53 determinants during tumorigenesis in mice J. Immunol. 164 2000 5641 5651
36. +T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients Proc. Natl. Acad. Sci. U. S. A. 99 2002 11813 11818
37. S.L. Topalian Revelation of a cryptic major histocompatibility complex class II-restricted tumor epitope in a novel RNA-processing enzyme Cancer Res. 62 2002 5505 5509
38. K.M. Lally Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading Int. J. Cancer 93 2001 841 847
39. A.D. Hess The N-terminal flanking region of the invariant chain peptide augments the immunogenicity of a cryptic 'self' epitope from a tumor-associated antigen Clin. Immunol. 101 2001 67 76
40. S. Tourdot A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes Eur. J. Immunol. 30 2000 3411 3421